The FDA’s... Investing.com -- Shares of Philip Morris International Inc. (NYSE:PM) rose 1% following the U.S. Food and Drug Administration's (FDA) authorization of 20 ZYN nicotine pouch ...

Philip Morris International Inc.’s (PMI) (NYSE: PM) Chief Executive Officer, Jacek Olczak, and Chief Financial Officer, Emmanuel Babeau, will address investors today at the 2025 Consumer Analyst Group ...

STAMFORD, CT, February 12, 2025--(BUSINESS WIRE)--Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast of a presentation by Jacek Olczak, Chief ...

Cannabis pouches emerge as an alternative to smoking, but can they match Zyn's success? Experts weigh in on market potential ...

Denver City Council’s crusade against flavored nicotine products continues to vex those of us who, as a matter of civic ...

Philip Morris International had a net margin of 9.24% and a negative return on equity of 120.08%. As a group, sell-side analysts predict that Philip Morris International will post 7.11 EPS for the ...

The presentation, related discussion and this press release contain projections of future results and goals and other forward-looking statements, including statements regarding expected financial ...